Delivery Order SPE2DB22D2206-SPE2DB25FGD09
Award Date
3/17/25
Potential Completion Date
4/7/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 40 MG TABLET 30S. The contract is a firm fixed-price delivery order with a ceiling value of $15,346.55 and a performance period through March 5, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $15,346.55 contract is for the supply of CABOMETYX 40 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,346.55, is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cabometyx 60 mg tablets. The contract has a firm fixed price of $15,301.05 and a period of performance through May 14, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,301.05, is for the supply of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2025 and is a Firm Fixed Price contract. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,346.55, is for the delivery of the drug CABOMETYX 40 MG TABLET 30S. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 9, 2025. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 60 MG TABLET 30S. The contract is a firm fixed-price delivery order with a ceiling value of $55,633.12 and a completion date of September 20, 2024. The contract is not set aside for any specific business category. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts and Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,301.05 firm fixed-price delivery order is for the supply of CABOMETYX 60 MG TABLET 30S, a medication used in the treatment of certain types of cancer. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $30,693.10, is for the delivery of 4,567,984,745 units of the medication CABOMETYX 40 MG TABLET 30S. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $27,734.36 and is for the delivery of the pharmaceutical product CABOMETYX 40 MG TABLET 30S. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...